Aua Capital Management, LLC Pfizer Inc Transaction History

Aua Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$26.13 - $33.94 $127,409 - $165,491	-4,876 Reduced 36.9%	8,337 $240,000
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $38,893 - $45,462	1,212 Added 10.1%	13,213 $438,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $111,305 - $145,297	2,666 Added 28.56%	12,001 $615,000
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $66,165 - $80,771	-1,512 Reduced 13.94%	9,335 $408,000
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $21,548 - $26,700	471 Added 4.54%	10,847 $562,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $201,476 - $298,655	4,876 Added 88.65%	10,376 $613,000
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $70,650 - $90,756	-1,800 Reduced 24.66%	5,500 $237,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $66,675 - $78,225	2,100 Added 40.38%	7,300 $268,000
Q2 2020 Jul 13, 2020	SELL	$30.12 - $36.54 $63,252 - $76,734	-2,100 Reduced 28.77%	5,200 $170,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $13,561 - $15,733	-425 Reduced 5.5%	7,300 $260,000
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $239,475 - $263,808	7,725	7,725 $276,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.